Evidence map›Paper›PMID 39622508›Full record

ArticleJournal of breast cancer2024

Characteristics and Prognosis of Breast Cancer Patients With Prior Hormone Replacement Therapy: Insights From the Korean Breast Cancer Society Registry.

Chai Won Kim, Yongsik Jung, Joon Jeong, Hee Jeong Kim, Jung Eun Choi, Young Jin Suh, Ku Sang Kim, Woo Chan Park, Chang Ik Yoon, Young Joo Lee and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of breast cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chai Won KimDepartment of Surgery, The Catholic University Graduate School, Seoul, Korea.ORCID https://orcid.org/0000-0001-9465-1151
Yongsik JungDivision of Breast Surgery, Department of Surgery, Ajou University Medical Center, Ajou University, School of Medicine, Suwon, Korea.ORCID https://orcid.org/0000-0002-2011-1459
Joon JeongDivision of Breast Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University Medical College, Seoul, Korea.ORCID https://orcid.org/0000-0003-0397-0005
Hee Jeong KimDivision of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1343-8138
Jung Eun ChoiDivision of Breast Surgical Oncology, Department of Surgery, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.ORCID https://orcid.org/0000-0002-1800-7943
Young Jin SuhDivision of Breast and Thyroid Surgical Oncology, Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.ORCID https://orcid.org/0000-0003-1033-3848
Ku Sang KimDivision of Breast Surgery, Department of Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.ORCID https://orcid.org/0000-0003-2710-112X
Woo Chan ParkDivision of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0002-1265-1981
Chang Ik YoonDivision of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0002-7273-8886
Young Joo LeeDivision of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0001-5352-8093
Dooreh KimDivision of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0003-1758-4439
Soo Youn BaeDivision of Breast Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. baessu@gmail.com.ORCID https://orcid.org/0000-0003-0551-7618
Korean Breast Cancer Society

Funding

Korean Breast Cancer Society
6 · The paper itself

Abstract

By investigating the characteristics and prognosis of breast cancer (BC) patients who have undergone hormone replacement therapy (HRT), this study addresses a gap in the existing literature. A total of 17,355 postmenopausal patients with BC were analyzed using data from the Korea Breast Cancer Society database (2000-2014). Among them, 3,585 (20.7%) had a history of HRT before BC diagnosis (HRT group), while 13,770 (79.3%) never received HRT (non-HRT group). The HRT group exhibited an earlier pathologic stage, lower histologic and nuclear grades, and a higher rate of breast conservation surgery compared to the non-HRT group. Furthermore, this group had a higher rate of screening participation and a greater proportion of patients with a normal or overweight body mass index (BMI). The prognosis of the HRT group was better than that of the non-HRT group, with a 5-year overall survival rate of 93.9% versus 91.7% (

Indexed as

Breast NeoplasmsHormone Replacement TherapyPrognosisSurvival Rate

Identifiers

PMID39622508
PMCPMC11710908

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.